ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 1111

$657K Total Retail Price of All Prescriptions

Rank: 119 out of 1111

303 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 8,288 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 340 286 1 3
OMEPRAZOLE 311 259 2 4
LISINOPRIL 267 251 3 2
HYDROCODONE-ACETAMINOPHEN 267 189 S3 3 1
FUROSEMIDE 266 251 5 6
CITALOPRAM HBR 243 211 6 14
SIMVASTATIN 233 207 7 5
AMLODIPINE BESYLATE 221 201 8 7
GABAPENTIN 205 162 9 10
HYDROCHLOROTHIAZIDE 182 168 10 11
POTASSIUM CHLORIDE 181 173 11 9
METFORMIN HCL 176 133 12 8
WARFARIN SODIUM 160 148 13 19
ZOLPIDEM TARTRATE 141 105 14 16
NAMENDA 134 134 15 31
MELOXICAM 126 117 16 18
DONEPEZIL HCL 115 115 17 25
ATORVASTATIN CALCIUM 112 98 18 15
TRAMADOL HCL 109 55 19 13
CLOPIDOGREL 101 94 20 30
PRAVASTATIN SODIUM 101 95 20 17
CYMBALTA 98 53 22 40
LOSARTAN POTASSIUM 96 96 23 34
ATENOLOL 94 94 24 22
QUETIAPINE FUMARATE 92 58 25 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 84 26 23
POLYETHYLENE GLYCOL 3350 86 73 27 45
FLUTICASONE PROPIONATE 83 68 28 27
SERTRALINE HCL 81 73 29 24
DIVALPROEX SODIUM 80 56 30 82
OXYBUTYNIN CHLORIDE ER 77 40 31 114
CARVEDILOL 77 52 31 21
GLIPIZIDE 74 74 33 57
ESCITALOPRAM OXALATE 71 61 34 78
METOPROLOL TARTRATE 67 54 35 12
ALLOPURINOL 66 66 36 36
KLOR-CON M20 66 65 36 79
TAMSULOSIN HCL 66 64 36 28
OXYCODONE-ACETAMINOPHEN 63 63 S2 39 147
SINGULAIR 63 63 39 112
LIDODERM 63 63 39 198
NYSTATIN 63 39 39 151
CIPROFLOXACIN HCL 63 56 39 58
PREDNISONE 61 56 44 48
CARBIDOPA-LEVODOPA 60 60 45 101
LANTUS 60 51 45 46
PANTOPRAZOLE SODIUM 59 57 47 50
FAMOTIDINE 59 49 47 77
CARBAMAZEPINE 58 12 49 196
BACLOFEN 57 0 50 119
RISPERIDONE 56 33 51 60
MIRTAZAPINE 56 52 51 52
NOVOLOG 56 50 51 104
PLAVIX 55 50 54 49
DIOVAN 53 50 55 51
LEVETIRACETAM 53 36 55 111
NITROFURANTOIN MONO-MACRO 52 42 57 149
JANUVIA 51 51 58 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.